How Amendment Intelligence Helps Reduce Avoidable Protocol Revisions
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger […]
Clinical development teams can use operational and institutional review board (IRB) data to identify protocol-design risks before those risks trigger […]
Clinical trial study startup requires constant coordination across sponsors, contract research organizations (CROs), research sites, and institutional review boards (IRBs).
Clinical research increasingly depends on electronic systems to support core trial documentation, data handling, and regulated workflows. That shift has
Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never looked back. Now a team lead supporting
How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions Choosing the right sites can
IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight process. For sponsors, approval marks
MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape how teams show up for
Institutional review board (IRB) approval is a critical milestone in clinical research, but it can also become a source of
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
Multisite research and clinical trials increasingly rely on a single IRB (sIRB) for review. This increase reflects federal mandates, sponsor expectations, and the operational realities of modern multisite or cooperative research. For institutions with a local
A strong protocol and well-drafted consent form are essential, but they are not enough on their own to support a
Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s about people. As associate director of